Stocks and Investing Stocks and Investing
Thu, February 9, 2017
Wed, February 8, 2017

Robyn Karnauskas Upgraded (BIIB) to Strong Buy on, Feb 8th, 2017


Published on 2024-10-25 20:12:18 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Citigroup, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, Feb 8th, 2017.

Robyn has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 2 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Initiated at Hold and Held Target at $293 on, Friday, December 16th, 2016
  • Salim Syed of "Mizuho" Initiated at Hold and Held Target at $290 on, Tuesday, November 8th, 2016


These are the ratings of the 2 analyists that currently disagree with Robyn


  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy on, Monday, November 7th, 2016
  • Geoffrey Porges of "Leerink Swann" Upgraded from Hold to Buy on, Monday, November 7th, 2016

Contributing Sources